Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents Ruchika Sharma6 Dec 2022 1:30 PM ISTPfizer and BioNTech said in their Monday filing that they developed their vaccine independently, calling Moderna's lawsuit "revisionist history" and...
Pfizer, BioNTech seek USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in children under 5 years Ruchika Sharma6 Dec 2022 11:30 AM ISTNew York: Pfizer and BioNTech have announced that the companies have submitted an application to the U.S. Food and Drug Administration (USFDA) for...
Pfizer, Roivant form company to develop ulcerative colitis treatment Ruchika Sharma4 Dec 2022 3:45 PM ISTPfizer owns a 25% equity position in the Vant and maintains commercial rights outside of the US and Japan as well as representation on the company's...
Medical Bulletin 26/November/2022 Dr. Nandita Mohan26 Nov 2022 1:00 PM ISTHere are the top medical news for the day:Risk of severe asthma attacks doubled after Covid-19 restrictions liftedAdults with asthma had, at one...
Apixaban patent Violation: HC reprimands BDR Pharma for callousness in implementing court order Farhat Nasim24 Nov 2022 12:24 PM ISTNew Delhi: Coming down heavily on BDR Pharmaceuticals International, the Delhi High Court has warned the Mumbai-based drug maker against its 'callous...
Glenmark Pharma settles with Pfizer for Axitinib Tablets Ruchika Sharma22 Nov 2022 2:30 PM ISTMumbai: Glenmark Pharmaceuticals Inc., USA (Glenmark) and Glenmark Pharmaceuticals Limited have reached a settlement agreement with Pfizer ...
Alembic Pharma bags USFDA nod for Hypertension drug Nifedipine Extended Release Ruchika Sharma21 Nov 2022 2:30 PM ISTNifedipine Extended-Release Tablets are indicated for the management of i) Vasospastic Angina ii) Chronic Stable Angina (Classical EffortAssociated...
Pfizer Indian arm reports profit jump on lower costs, price hikes Ruchika Sharma13 Nov 2022 3:30 PM ISTPfizer's revenue from operations rose 0.3% to 6.38 billion rupees.
Pfizer, BioNTech get positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for children 5 through 11 years of age in EU Ruchika Sharma13 Nov 2022 2:00 PM IST-New York: Pfizer Inc. and BioNTech SE have announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY...
Paxlovid antiviral therapy reduces risk of long COVID Roshni Dhar10 Nov 2022 5:41 PM ISTPfizer Inc.'s blockbuster Paxlovid antiviral that lowers rates of illness and death in people infected with the coronavirus also cuts the risk of some...
Pfizer-BioNTech COVID booster targeting Omicron BA.4/5 approved in Britain Ruchika Sharma10 Nov 2022 10:00 AM ISTThe regulator on Wednesday also approved Novavax's COVID-19 shot as a booster for adults.
Myocarditis Risk Two-Threefold Higher with Moderna Vaccine than Pfizer: JACC Study Kajal Rajput9 Nov 2022 8:00 PM ISTWASHINGTON: Choice of COVID-19 vaccine is indeed dependant on possiblities of side efffects associated with them A study published recently in the...
